Oral versus intravenous antibiotic treatment of moderate-to-severe community-acquired pneumonia: a propensity score matched study

Anna G. Kaal,Rick Roos,Pieter de Jong,Rianne M. C. Pepping,Johanna M. W. van den Berg,Maarten O. van Aken,Ewout W. Steyerberg,Mattijs E. Numans,Cees van Nieuwkoop

DOI: https://doi.org/10.1038/s41598-024-59026-2

IF: 4.6

2024-04-11

Scientific Reports

Abstract:Community-acquired Pneumonia (CAP) guidelines generally recommend to admit patients with moderate-to-severe CAP and start treatment with intravenous antibiotics. This study aims to explore the clinical outcomes of oral antibiotics in patients with moderate-to-severe CAP. We performed a nested cohort study of an observational study including all adult patients presenting to the emergency department of the Haga Teaching Hospital, the Netherlands, between April 2019 and May 2020, who had a blood culture drawn. We conducted propensity score matching with logistic and linear regression analysis to compare patients with moderate-to-severe CAP (Pneumonia Severity Index class III–V) treated with oral antibiotics to patients treated with intravenous antibiotics. Outcomes were 30-day mortality, intensive care unit admission, readmission, length of stay (LOS) and length of antibiotic treatment. Of the original 314 patients, 71 orally treated patients were matched with 102 intravenously treated patients. The mean age was 73 years and 58% were male. We found no significant differences in outcomes between the oral and intravenous group, except for an increased LOS of + 2.6 days (95% confidence interval 1.2–4.0, p value < 0.001) in those treated intravenously. We conclude that oral antibiotics might be a safe and effective treatment for moderate-to-severe CAP for selected patients based on the clinical judgement of the attending physician.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to compare the clinical effects of oral antibiotic treatment and intravenous antibiotic treatment in patients with moderate - to - severe community - acquired pneumonia (CAP, Pneumonia Severity Index (PSI) classification III - V) who are treated in the emergency department (ED). Specifically, the study aims to explore whether, in daily clinical practice, for patients with moderate - to - severe CAP, based on the clinical judgment of emergency department physicians, the use of oral antibiotics can be a safe and effective alternative treatment option to intravenous antibiotics.

The research background indicates that current European and American guidelines generally recommend hospitalization and the use of intravenous antibiotics for patients with moderate - to - severe CAP. However, some studies have shown that for certain specific CAP patient groups, oral antibiotics may be equally effective or even more effective. Therefore, through retrospective cohort analysis combined with the propensity score matching (PSM) method, this study evaluated the differences in clinical outcomes such as 30 - day mortality, intensive care unit (ICU) admission rate, readmission rate, length of stay (LOS), and duration of antibiotic treatment between oral antibiotic treatment and intravenous antibiotic treatment.

The research results show that, except that the length of stay in the intravenous injection group was significantly longer than that in the oral group (an average increase of 2.6 days, 95% confidence interval 1.2 - 4.0, p - value < 0.001), there were no significant differences between the two groups in terms of 30 - day mortality, ICU admission rate, and readmission rate. This indicates that in selected patients with moderate - to - severe CAP, according to the clinical judgment of emergency department physicians, oral antibiotics may be a reasonable and effective treatment option.